Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Inv. presentation
Quarterly results
|
|
DELCATH SYSTEMS, INC. (DCTH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/21/2021 |
GN
| Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United Kingdom |
| 03/31/2021 |
GN
| Delcath Systems, Inc. Shares Additional Information Regarding FOCUS Trial Power Calculation |
| 03/31/2021 |
GN
| Delcath Systems, Inc. Announces Fourth Quarter 2020 Results, Highlights Preliminary Positive FOCUS Trial Results; Conference Call Today at 8:00am Eastern Time |
| 03/31/2021 |
GN
| Delcath Systems, Inc. Announces Positive Preliminary Results from Phase 3 FOCUS Trial of HEPZATO in Patients with Metastatic Ocular Melanoma |
| 02/11/2021 |
GN
| Delcath Systems to Participate at Upcoming Virtual Investor Conferences |
| 01/11/2021 |
GN
| Delcath Systems to Present at the H.C. Wainwright Virtual BioConnect Conference |
| 12/11/2020 |
GN
| Delcath Systems Announces Completion of Underwritten Public Offering |
| 12/08/2020 |
GN
| Delcath Systems Announces Proposed Public Offering of Common Stock |
| 12/07/2020 |
GN
| Kevin Muir Joins Delcath Systems, Inc. as VP, Commercial Operations |
| 11/11/2020 |
GN
| Delcath Systems, Inc. Announces Third Quarter 2020 Results |
| 10/01/2020 |
GN
| Delcath Strengthens Executive Team with Appointment of Gerard Michel as Chief Executive Officer |
| 08/25/2020 |
GN
| Delcath to Present at the LD Micro 500 Virtual Investor Conference on Tuesday, September 1, 2020 at 3:00pm ET |
| 08/03/2020 |
GN
| Delcath to Present at Canaccord Genuity 40th Annual Growth Conference |
| 05/15/2020 |
GN
| Delcath Announces First Quarter 2020 Results |
| 05/01/2020 |
GN
| Delcath Systems Announces Pricing of $22 Million Public Offering and Uplisting to the Nasdaq Capital Market |
| 09/14/2017 |
GN
| Delcath Announces Accelerated Listing on OTCQB |
| 09/13/2017 |
GN
| Delcath Announces Relisting on OTCQB |
| 09/01/2017 |
GN
| Delcath Issues Letter to Stockholders |
| 08/29/2017 |
GN
| Delcath Announces Medical University of Hannover in Germany Celebrates 100th CHEMOSAT Treatment |
| 08/22/2017 |
GN
| Delcath Systems, Inc. Announces Extension of Expiration Date of its Consent Solicitation and Ability to Change Consent Once Voted |
| 06/05/2017 |
GN
| Delcath Systems, Inc. Announces Adjournment of Annual Meeting Meeting Scheduled to Reconvene on June 16 |
| 05/09/2017 |
GN
| Delcath Announces First Quarter 2017 Financial Results |
| 04/27/2017 |
GN
| Delcath Issues Letter to Stockholders |
| 04/18/2017 |
GN
| Spire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments |
| 03/29/2017 |
GN
| Delcath Announces 2016 Financial Results |
| 03/10/2017 |
GN
| Delcath Systems To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 13, 2017 |
| 02/22/2017 |
GN
| Published Review Shows Delcath Investigational PHP Doubles Overall Survival Over Other Targeted Liver Therapies |
|
|